Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
382 Leser
Artikel bewerten:
(1)

Kemira Oyj: Kemira acquires liquid fingerprinting technology from Finnish start-up Aqsens

Kemira Oyj
Press release
June 29, 2017 at 3 pm (CET +1)

Kemira acquires liquid fingerprinting technology from Finnish start-up Aqsens

Kemira Oyj acquires liquid fingerprinting technology for qualitative and quantitative liquid analyses from start-up Aqsens Oy, headquartered in Helsinki, Finland. This technology utilizes Enhanced Time Resolved Fluorescence (E-TRF) method that enables high sensitivity and selectivity to monitor various liquid samples.

The first application where this technology has been used is Kemira KemConnect SI system, which measures residual polymeric scale inhibitor concentration from oil field waters in a few minutes. Reliable real-time data on-site improves operators' treatment effectiveness and maximizes the production.

"The acquisition demonstrates Kemira's commitment to acquire new technology that improves our capabilities to provide smart chemical monitoring tools for our customers. We look forward to develop this technology further to become a vital part of Kemira KemConnect process management package in multiple applications" says Antti Salminen, President, Industry & Water.

"Aqsens has decided to refocus the company's business on Health Monitoring, and we are delighted to see our long-term partner Kemira to continue the development and business activities with the jointly developed E-TRF technology platform", says Timo Teimonen, CEO, Aqsens Health Oy.

The parties have agreed not to disclose the transaction price.

For more information, please contact

Kemira Oyj
Antti Salminen, President, Industry & Water
Tel. +358 50 378 0840

Aqsens Health Oy
Timo Teimonen, CEO
Tel. +358 40 585 3105
 

Kemira is a global chemicals company serving customers in water-intensive industries. We provide expertise, application know-how and chemicals that improve our customers' product quality, process and resource efficiency. Our focus is on pulp & paper, oil & gas and water treatment. In 2016, Kemira had annual revenue of around EUR 2.4 billion and 4,800 employees. Kemira shares are listed on the Nasdaq Helsinki Ltd.
www.kemira.com (http://www.kemira.com/en/pages/default.aspx)
 
Aqsens is a technology startup delivering novel applications for qualitative and quantitative liquid analyses. Its E-TRF method provides high level of sensitivity, ease of use together with unsurpassed accuracy even on-site. Company's vision is to become a leading technology company in on-site liquid analyses applications focusing on Cleantech and Life-Science Businesses.
www.aqsens.com (http://www.aqsens.com/), www.aqsenshealth.com (http://www.aqsenshealth.com/)




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Kemira Oyj via Globenewswire

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.